South Africa’s drugs regulator to start assessing Sinovac COVID-19 vaccine

COVID-19 mass vaccination program for vendors and workers in Tangerang

JOHANNESBURG (Reuters) – South Africa’s medicines regulator SAHPRA said on Friday that it had received documentation for the COVID-19 vaccine developed by China’s Sinovac.

It added in a statement that it would now start evaluating the data and assessing the efficacy of the vaccine.

(Reporting by Alexander Winning; Editing by Christopher Cushing)

More from our Sister Sites